
AAOS 2016: Liposomal bupivacaine vs femoral nerve block for postoperative ACLR pain

AAOS 2016: Liposomal bupivacaine vs femoral nerve block for postoperative ACLR pain
Liposomal Bupivacaine Versus Femoral Nerve Block in Managing Pain After Anterior Cruciate Ligament Reconstruction
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
100 patients who underwent arthroscopic anterior cruciate ligament reconstruction (ACLR) were randomized to either intraoperative local infiltration of liposomal bupivacaine (LB) or femoral nerve block (FNB) for the management of postoperative pain. The objective of this study was to compare the effectiveness of the two treatments in postoperative pain management, opioid consumption, sleep disturb...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.